Related Experiment Videos
Molecular basis of endometrial cancer
1Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Background:
Most human cancers are thought to arise from alterations in oncogenes and tumor suppressor genes.
Methods:
Molecular techniques have been used to identify specific genetic alterations in endometrial cancers.
Results:
Overexpression of the HER-2/neu oncogene occurs in 10% of endometrial cancers and correlates with poor survival. Alterations in other receptor tyrosine kinases (c-fms and epidermal growth factor receptor) also occur in some cases. The c-myc oncogene, which encodes a nuclear transcription factor, also may be overexpressed in some invasive cancers. Mutations in the K-ras oncogene occur in 10% and in 20-30% of American and Japanese endometrial cancers, respectively. K-ras mutations also have been observed in endometrial hyperplasias, and this may represent an early event in the development of some cancers. Mutation of the p53 tumor suppressor gene, with resultant overexpression of mutant p53 protein, occurs in 20% of endometrial adenocarcinomas. Overexpression of p53 is associated with advanced stage and poor survival. Because p53 mutations do not occur frequently in endometrial hyperplasias, this may be a relatively late event in endometrial carcinogenesis. Recent studies have shown that mutations occur in microsatellite sequences in some endometrial cancers. Because microsatellite instability in hereditary nonpolyposis colon cancer has been found to be caused by mutations in DNA repair genes, similar mutations are being sought in endometrial cancers.
Conclusions:
Although several molecular alterations have been identified, the molecular pathogenesis of endometrial cancer remains poorly understood.
Insights
Genetic alterations in oncogenes and tumor suppressor genes are implicated in endometrial cancer. Key mutations in HER-2/neu, K-ras, and p53 genes are observed, but the overall molecular pathogenesis remains unclear.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Human cancers often originate from genetic changes in oncogenes and tumor suppressor genes.
- Understanding these alterations is crucial for diagnosing and treating various cancer types.
Purpose of the Study:
- To identify specific genetic alterations in endometrial cancers.
- To investigate the role of oncogenes and tumor suppressor genes in endometrial carcinogenesis.
Main Methods:
- Utilized molecular techniques to detect genetic changes in endometrial cancer samples.
- Analyzed alterations in specific genes including HER-2/neu, c-fms, epidermal growth factor receptor, c-myc, K-ras, and p53.
- Investigated mutations in microsatellite sequences and potential DNA repair gene involvement.
Main Results:
- HER-2/neu oncogene overexpression observed in 10% of endometrial cancers, correlating with poor survival.
- Mutations in K-ras oncogene found in 10% (American) and 20-30% (Japanese) of endometrial cancers, potentially an early event.
- p53 tumor suppressor gene mutations and overexpression occurred in 20% of adenocarcinomas, associated with advanced stage and poor survival, possibly a late event.
- Microsatellite sequence mutations were identified in some endometrial cancers, prompting investigation into DNA repair gene mutations.
Conclusions:
- Identified several molecular alterations in endometrial cancer.
- The precise molecular pathogenesis of endometrial cancer requires further investigation.
- Further research is needed to elucidate the role of DNA repair gene mutations in endometrial carcinogenesis.